UBS advice for Schott Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| November 28, 2024 | UBS | Schott Pharma | Hold | 32.60 EUR | 25.95 % |
Advice details
London - Op 28 nov herhalen de analisten van UBS hun houdadvies voor Schott Pharma (). Het 12-maands koersdoel blijft gehandhaafd op 32.6 EUR.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 